Speakers

Session 1 – Setting the Scene

Raymond F. Schinazi, Emory University School of Medicine, USA
Jeffery K. Taubenberger, National Institutes of Health, USA
Teresa Compton, Biogen Idec, USA

Session 2 – Emerging viruses

Colleen B. Jonsson, Center for Predictive Medicine, USA
Subhash Vasudevan, Duke-NUS Graduate Medical School, Singapore

Session 3 – Drug discovery

Elena Govorkova, St. Jude Children’s Research Hospital, Memphis TN, USA
Ann Kwong, Vertex Pharmaceuticals, Inc, USA

CONRAD Symposium –The use of antiviral agents to prevent transmission of HIV-1
Tom Hope, USA
Gustavo Doncel, USA
Patrick Kiser, USA
David R. Friend, CONRAD, USA

Session 4 – Antiviral resistance

Giorgio Palù, University of Padova, Italy

Session 5 – Clinical trials & Field studies

Alan C. Jackson, University of Manitoba Health Sciences Centre, Canada

Session 6 – Virus-Host interactions

Warren L. Lee, University of Toronto, Canada

Session 7 – New antiviral drugs

Fabien Zoulim, INSERM, France

Session 8 – Future Challenges

Sujan Shresta, La Jolla Institute for Allergy and Immunology, USA